InhaleRx Ltd (ASX: IRX) Share Price and News
Price
$0.04
Movement
0.001 (+2.56%)
as at 6 Jun - Closed (20 mins delayed)
52 Week Range
$0.018 - $0.05
1 Year Return
+33.33%
InhaleRx Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$8.54 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
213.45 million
Earnings per share
-0.006
Dividend per share
N/A
Year To Date Return
14.29%
Earnings Yield
N/A
Franking
-
Share Price
$0.04
Day Change
0.001 (+2.56%)
52 Week Range
$0.018 - $0.05
Yesterday's Close
$0.039
Today's Open
$0.039
Days Range
$0.039 - $0.042
Volume
710,752
Avg. Volume (1 month)
149,620
Turnover
$29,379
as at 6 Jun - Closed
InhaleRx Ltd (ASX: IRX)
Latest News
No posts found.
IRX ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|
About InhaleRx Ltd
InhaleRx Ltd. engages in the development and commercialization of medical technologies. Its products include BodyTel Systems and Seng Vital Cannabis Vaporisers. The company was founded on April 13, 2016 and is headquartered in Sydney, Australia.
IRX Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Jun 2025 | $0.04 | $0.00 | 0.00% | 710,752 | $0.04 | $0.04 | $0.04 |
| 05 Jun 2025 | $0.04 | $0.01 | 30.30% | 1,413,776 | $0.03 | $0.04 | $0.03 |
| 04 Jun 2025 | $0.03 | $0.00 | 0.00% | 39,393 | $0.03 | $0.03 | $0.03 |
| 03 Jun 2025 | $0.03 | $0.00 | 0.00% | 21,000 | $0.03 | $0.03 | $0.03 |
| 02 Jun 2025 | $0.03 | $0.00 | 0.00% | 323,067 | $0.03 | $0.03 | $0.03 |
| 30 May 2025 | $0.03 | $0.00 | 0.00% | 156,933 | $0.03 | $0.03 | $0.03 |
| 29 May 2025 | $0.03 | $0.00 | 0.00% | 144,900 | $0.03 | $0.03 | $0.03 |
| 20 May 2025 | $0.03 | $0.00 | 0.00% | 157,753 | $0.03 | $0.03 | $0.03 |
| 15 May 2025 | $0.03 | $0.00 | 0.00% | 270,130 | $0.03 | $0.03 | $0.03 |
| 14 May 2025 | $0.03 | $0.00 | 0.00% | 150,000 | $0.03 | $0.03 | $0.03 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 16 Dec 2024 | Sean Williams | Issued | 741,143 | $24,815 |
Director remuneration.
|
| 16 Dec 2024 | James Barrie | Issued | 492,792 | $16,500 |
Director remuneration.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Ronald Wise | Non-Executive Director | Nov 2024 |
Dr Wise lectured at UWA in the Department of Biochemistry for 2 years, followed by research at Princess Margaret Children's Hospital in WA. Ron then became involved in mineral exploration and was Chairman of companies responsible for discovering the Woodada Gas Field and the Mt Percy Gold Mine. In recent times he has been involved as Chairman and co-founder of Selvax Pty Ltd, an immunotherapy drug development company, which is expanding on work carried out by the team of Dr Delia Nelson at Curtin University.
|
| Mr Tony Fitzgerald | Non-Executive Director | Feb 2025 |
Mr Fitzgerald is a Life Sciences entrepreneur, technologist and company director with multi-country experience in private and public companies. Currently the CEO of molecular diagnostics company Avicena Systems Limited, Mr Fitzgerald has been the Founder of ASX listed medical AI imaging company Resonance Health and cancer immunology company Selvax Pty Ltd, both medical technology spin outs from Australian universities, Co-Founder of the Alerte group of AI technology companies including Alerte Digital Health and Singulariti Systems, and Avicena Systems Limited, the molecular diagnostics company that was named Australian tech startup of the year in the 2021 national iAwards, Has served as director of various public companies over a twenty-five-year period.
|
| Mr Sean Williams | Non-Executive ChairmanNon-Executive Director | Jul 2021 |
Mr Williams has over 30 years of experience in senior executive and finance roles across the pharmaceutical, healthcare, investment management and supply chain sectors. Having commenced his career with an international accounting firm, Sean has held several senior roles including General Manager, Finance for Symbion Pharmacy. He also headed up Symbion's market leading hospital pharmacy and dental divisions and was responsible for Independent Pharmacy Solutions (a short-line wholesale business). Sean has worked as an investment director in private equity and as a senior executive in private equity backed ventures. He has also led management buy-outs and been involved in founding start-up businesses within the supply chain sector. Most recently, Sean was CEO of a $500m investment management business specializing in Australian agricultural investments.
|
| Mr James Stephen Barrie | Company Secretary | Aug 2023 |
Mr Barrie is a Company Secretary and Director and brings experience as a Director of several listed and unlisted pharmaceutical, bio-tech and med-tech companies.
|
| Mr Darryl Davies | Chief Executive Officer | Jul 2021 |
-
|
| Darryl Davies | Chief Executive Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cannvalate Pty Ltd | 48,330,887 | 22.64% |
| 10 Bolivianos Pty Ltd | 24,956,453 | 11.69% |
| Pyxis Holdings Pty Ltd (The Mapletree A/C) | 17,200,000 | 8.06% |
| Finclear Services Pty Ltd (Superhero Securities A/C) | 10,704,009 | 5.01% |
| Mcann Investments Pty Ltd | 8,000,000 | 3.75% |
| Dr David James Walland | 6,804,291 | 3.19% |
| Parim Singh Harman Singh | 6,249,999 | 2.93% |
| BNP Paribas Nominees Pty Ltd (Clearstream) | 5,063,805 | 2.37% |
| Mr Sean Christopher Reeves | 4,386,545 | 2.06% |
| Mr Michael James Reid | 4,150,501 | 1.94% |
| Citicorp Nominees Pty Limited | 3,623,477 | 1.70% |
| Darryl Davies | 3,444,828 | 1.61% |
| Mr Niv Dagan | 3,282,013 | 1.54% |
| BNP Paribas Noms Pty Ltd | 3,219,901 | 1.51% |
| HSBC Custody Nominees (Australia) Limited | 2,799,928 | 1.31% |
| Bliss On Banksia Hairdressing Pty Ltd (The Stefanest Egg Sfund A/C) | 2,362,956 | 1.11% |
| Sassey Pty Ltd (Sassey A/C) | 2,192,985 | 1.03% |
| Mr Piper Belesprit Madison | 1,800,038 | 0.84% |
| Little Bell Resources Pty Ltd | 1,591,504 | 0.75% |
| BNP Paribas Nominees Pty Ltd (Ib Au Noms Retailclient) | 1,563,944 | 0.73% |